Back Stocks profile

Stock analysis tool for investors

Veerhealth Care Ltd.

NSE: NIYATILEAS | BSE:511523

₹21.01 -0.03 (-0.14%) 1D

Pharmaceuticals & Biotechnology

Open an Account with Bigul in 5 minutes

Performance

Today’s low

20.40

Today’s High

22.00

52W low

13.60

52W High

30.10

Open Price

21.30

Prev. Close

21.2900

Volume

40416.00

Value

849140.16

Fundamentals

Market Cap

42.00

Price to Earnings

112.80

Price to Book Value

1.90

Dividend Yield

0.00

PE to Growth

-1.50

Op Revenue TTM

13.65

Net Profit TTM

0.37

Cash From Operating Activity

2.90

Return on Equity %

1.85

EMA & SMA

Bullish Moving Averages

2

Bearish Moving Averages

14

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

05 Jul, 2024

76.2

Week

86

Month

79.5

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

21.13

PIVOT

First Resistance

21.87

Second Resistance

22.72

Third Resistance

23.46

First Support

20.28

Second Support

19.54

Third Support

18.69

Relative Strength Index

47.49

Money Flow Index

62.06

MACD

-0.04

MACD Signal

0.01

Average True Range

1.35

Average Directional Index

9.99

Rate of Change (21)

-2.78

Rate of Change (125)

-2.1

Commodity Channel Index

-44.6

Williams %R

-68.4

BETA

1 Month

0.15

3 Month

-0.51

1 Year

-0.12

3 Year

-0.09

PRICE CHANGE ANALYSIS

0.38%

1 Week

Low

High

20.4

21.99

-1.32%

1 Month

Low

High

20

23.2

-12.82%

3 Months

Low

High

18

23.62

-6.66%

6 Months

Low

High

18

30.1

30.01%

1 Year

Low

High

13.6

30.1

Bigul
26 Jun 2024

Veerhealth Care Limited - 511523 - Closure of Trading Window

Intimation of Closure of Trading Window
Bigul
26 Jun 2024

Veerhealth Care Limited - 511523 - Announcement under Regulation 30 (LODR)-Investor Presentation

Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, please find enclosed Investors Presentation on the Audited Financial Results for the quarter and year ended 31st March, 2024.
Bigul
19 Jun 2024

Veerhealth Care Limited - 511523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

In continuation of the letter dated June 08, 2024 related to the Investor Conference Call to discuss the Financial Results for the Quarter ended March 31, 2024 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the Transcripts of the Company''s Investor Call.
Bigul
14 Jun 2024

Veerhealth Care Limited - 511523 - 'Ayuveer' Products Now Available On Nykaa For Purchase

We are delighted to announce that our brand Ayuveer''s products have successfully completed the onboarding process on Nykaa''s mobile application and website.
Bigul
12 Jun 2024

Veerhealth Care Limited - 511523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

With reference to our letter dated June 08, 2024 related to the Investor Conference Call and pursuant to Regulations 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, and Guidance note issued by the Stock Exchange dated July 29, 2022, we hereby inform you that the audio call recording of the Company''s Investor Call to discuss the Financial Results for the Quarter ended March 31, 2024 is available on the website of the Company www.veerhealthcare.net. The link to access the said audio recording is: https://veerhealthcare.net/wp-content/uploads/2024/06/Earning-Concall-Audio-of-Veerhealth-Care-Limited-Q4-FY24.mp3 Mr. Bhavin Shah, Managing Director and Mr. Akash Shah, Chief Financial Officer were the Management attendees. It is further confirmed that no unpublished price sensitive information was shared/discussed in the meeting / call.
Bigul
08 Jun 2024

Veerhealth Care Limited - 511523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Management team of the Company shall be participating in Q4 FY23-24 earnings call scheduled on Wednesday, June 12, 2024 at 2.00 pm (IST) hosted by Kirin Advisors. Please find attached details of the invitation.
Bigul
30 May 2024

Veerhealth Care Limited - 511523 - Announcement Under Regulation 30 Of SEBI LODR - Appointment Of Internal And Secretarial Auditor

Please find attached herewith the details under Regulation 30 of SEBI LODR for appointment of Internal and Secretarial Auditor.
Bigul
30 May 2024

Veerhealth Care Limited - 511523 - Results-Financial Results For March 31, 2024

Please find attached Audited Financial Results for the quarter and year ended 31st March, 2024.
Bigul
30 May 2024

Veerhealth Care Limited - 511523 - Board Meeting Outcome for Outcome Of Board Meeting

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you about the outcome of the Meeting of the Board of Directors of the Company held today i.e. May 30, 2024 as under: 1. The Board has approved and taken on record Audited Financial Results for the quarter and year ended March 31, 2024. 2. To conserve resources of the Company, the Board has not recommended any dividend on equity shares of the Company for the financial year ended March 31, 2024. The Board Meeting commenced at 4.00 p.m. and concluded at 5.00 p.m.
Bigul
27 May 2024

Veerhealth Care Limited - 511523 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Please find enclosed Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2024.
See all News

FAQs

The latest market price of Veerhealth Care Ltd. on NSE was Rs. 21.01 as of today.

The opening share price of Veerhealth Care Ltd. was Rs. 21.30 as of today.

The 52-week high share price of Veerhealth Care Ltd. was Rs. 30.10.

The 52 week low share price of Veerhealth Care Ltd. was Rs. 13.60.

Please find Corporate actions section for more details.

The PE ratio of Veerhealth Care Ltd. is -1.50. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please find Corporate actions section for more details.

The latest bonus issue declared by Veerhealth Care Ltd. was as of 2023-09-22. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Veerhealth Care Ltd. was as of 2005-09-28. The split ratio declared in this issue was 10:1. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Veerhealth Care Ltd..

Close

Let's Open Free Demat Account